Correlation Between Cellink AB and Boston Scientific

Can any of the company-specific risk be diversified away by investing in both Cellink AB and Boston Scientific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellink AB and Boston Scientific into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cellink AB and Boston Scientific, you can compare the effects of market volatilities on Cellink AB and Boston Scientific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellink AB with a short position of Boston Scientific. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellink AB and Boston Scientific.

Diversification Opportunities for Cellink AB and Boston Scientific

0.13

Correlation Coefficient

Cellink AB  Boston Scientific

Average diversification

The 3 months correlation between Cellink and Boston is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Cellink AB and Boston Scientific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boston Scientific and Cellink AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellink AB are associated (or correlated) with Boston Scientific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boston Scientific has no effect on the direction of Cellink AB i.e., Cellink AB and Boston Scientific go up and down completely randomly.

Pair Corralation between Cellink AB and Boston Scientific

Assuming the 90 days horizon Cellink AB is expected to generate 1.87 times more return on investment than Boston Scientific. However, Cellink AB is 1.87 times more volatile than Boston Scientific. It trades about 0.12 of its potential returns per unit of risk. Boston Scientific is currently generating about 0.05 per unit of risk. If you would invest  277.00  in Cellink AB on December 21, 2024 and sell it today you would earn a total of  75.00  from holding Cellink AB or generate 27.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cellink AB  vs.  Boston Scientific

Cellink AB

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cellink AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Cellink AB reported solid returns over the last few months and may actually be approaching a breakup point.

Boston Scientific

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Cellink AB and Boston Scientific

The main advantage of trading using opposite Cellink AB and Boston Scientific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellink AB position performs unexpectedly, Boston Scientific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will offset losses from the drop in Boston Scientific's long position.

The idea behind Cellink AB and Boston Scientific pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.